Cystic fibrosis: The miracle drugs priced out of reach
Regulators around the world have questioned the high price set by Vertex Pharmaceuticals.
Similar Posts
PM ‘not worried’ about Covid inquiry seeing messages
BBC political editor Chris Mason asked Rishi Sunak if the government was challenging the full release of messages between ministers and officials during the pandemic, to the Covid inquiry, because he was worried about something embarrassing him. The PM said: “Not at all”. He said it was “right that we learn the lessons of Covid”…
Burn treatment made from pineapples reduces need for skin grafting surgery: ‘New avenue of wound care’
Read this article for free! Plus get unlimited access to thousands of articles, videos and more with your free account! Please enter a valid email address. By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the content, check your…
Covid Inquiry: What have we learnt so far?
The first phase of the Covid Inquiry has come to an end. What have we learnt over the past six weeks?
India pharma exports soaring despite cough syrup deaths, trade body says | Reuters News Agency
Health 25 July 2023, 6:19 pm 1 minute Reuters exclusively reported that India’s pharmaceutical exports this fiscal year are set to grow nearly twice as fast as last year to hit sales of $27 billion, driven by strong U.S. buying, a government-backed trade body told Reuters, despite deaths linked to Indian-made cough syrups. Market Impact…
7 Things Stroke Doctors Say You Should Never, Ever Do
In the United States, strokes are a top cause of death and a major cause of disability, according to the American Stroke Association. This is a scary reality, especially since many of the stroke risk factors are pretty silent (like high cholesterol and high blood pressure) ― until they’re not. But just because some of…
At-home health test maker Thorne explores sale | Reuters News Agency
Business & FinanceDealsHealth 21 July 2023, 6:41 pm 1 minute Reuters exclusively reported that Thorne HealthTech Inc (THRN.O), a provider of at-home health tests and nutritional supplements, is exploring a sale. Market Impact Thorne’s shares ended trading on Friday up 12.9% at $5.95 on the news, giving the company a market value of $320 million….
